Robert Hoffman, Director at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), bought 10,000 shares at $2.40 ($24K) on 2014-12-16, disclosed to the SEC on 2014-12-17.
Open-market purchase of $24k MBVX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ARNA | SELL | 2013-04-03 | $585K | — | Filing → |
| ARNA | SELL | 2012-10-02 | $416K | — | Filing → |
| ARNA | SELL | 2012-07-09 | $110K | — | Filing → |